The sudden new crown pneumonia virus（COVID-19）at the end of 2019 caused great losses to the global medical device market，and also brought new opportunities and development directions，prompting the medical device industry to transform from low-end to mid-to-high-end. On the one hand，companies have increased their investment in technological innovation. On the other hand，the smart medical model has received unprecedented development opportunities in the epidemic. In 2020，domestic provinces have successively carried out volume-based procurement，and the profit structure has changed，thereby promoting the adjustment of the market structure and the centralization of the industry. The issuance of a series of medical device supervision regulations and the implementation of the unique identification code（UDI）for medical devices all heralds China’s improvement of medical device supervision and stricter quality control；While the registration certificate holder system brings new development opportunities for medical device companies，especially new companies. In 2020，Chinese orthopedic medical device market reached $460 million，and the localization rates of trauma，spine，and joints reached 72%，54% and 47% respectively. As the technology of domestic enterprises matures，the localization rate will further increase，and innovation is still the source of power for the sustainable development of Chinese orthopedic medical device market.